Hideho Okada

45PUBLICATIONS
221CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyGene and molecular therapyCellular nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (45)

|Jul 29, 2026
ITPKB is a conserved regulator of natural killer cell desensitization/education that constrains antitumor immunity.

|Jun 29, 2026
Systemic viral vector vaccination induces brain resident memory T cells to drive anti-glioblastoma immunity.

|Jun 26, 2026
In Vivo CAR-Based Immune Cell Engineering: Future Applications and Challenges in Malignant Glioma.

|May 29, 2026
Inhibition of chemokine CXCL12 modulates the tumor microenvironment in glioblastoma and potentiates immune checkpoint inhibitor efficacy in a tissue-specific manner.

|Apr 03, 2026
Spike-in probe-enhanced single-cell RNA-seq reveals post-infusion transcriptomic remodeling of "prime-and-kill" synNotch-CAR-T cells.

Takahide Nejo, Payal B Watchmaker, Milos S Simic

|Apr 01, 2026
Highlights in IO: next-generation CAR-T therapy for glioblastoma.

Junya Yamaguchi, Hideho Okada

Pageof 8

Frequent Collaborators

9 joint publications

Takahide Nejo

4 joint publications

Senthilnath Lakshmanachetty

4 joint publications

Pavlina Chuntova

3 joint publications

Ryusuke Hatae